Triple-negative breast cancers (TNBC) are characterized by lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2)1. This evidence concerns the gene PGR and triple-negative breast carcinoma.